Unknown

Dataset Information

0

Genomic Correlates of Exceptional Response to ErbB3 Inhibition in Head and Neck Squamous Cell Carcinoma.

ABSTRACT:

SUBMITTER: Faden DL 

PROVIDER: S-EPMC6705601 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
| S-EPMC4557203 | biostudies-literature
Unknown Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
| S-EPMC5849045 | biostudies-literature
Unknown Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
| S-EPMC6625877 | biostudies-literature
Proteomics Head and neck squamous cell carcinoma
2022-03-01 | PXD001438 | Pride
Unknown Head and neck squamous cell carcinoma.
| S-EPMC7944998 | biostudies-literature
Unknown Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma.
| S-EPMC3170587 | biostudies-literature
Unknown Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation.
| S-EPMC2394495 | biostudies-other
Unknown Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.
| S-EPMC5041982 | biostudies-literature
Unknown XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.
| S-EPMC3156890 | biostudies-literature
Unknown Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients.
| S-EPMC6820348 | biostudies-literature